Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M., Bdolah, Y., Lim, K.H., Yuan, H.T., Libermann, T.A., Stillman, I.E., Roberts, D., D’Amore, P.A., Epstein, F.H., Sellke, F.W., Romero, R., Sukhatme, V.P., Letarte, M. and Karumanchi, S.A. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine, 12, 642-649. doi:10.1038/nm1429

has been cited by the following article:

• TITLE: Placenta related pathogenic factors for preeclampsia

  AUTHORS: Yuxuan Chen, Zhenyu Zhang

  KEYWORDS: Preeclampsia; Biomarker; Angiogenic Factors; Transthyretin

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.2 No.4, November 9, 2012

  ABSTRACT: Preeclampsia (PE) is a life-threatening complication of pregnancy. The precise origin of PE remains obscure. Placenta has been considered to play a central role in its pathology. Here we present a brief overlook of placenta related pathogenic factors that might be involved in the pathology changes of PE. A series of factors that correlated with placenta pathology have been regarded attributed to the mechanism of the disease. Some of the factors may be confirmed to be useful biomarkers in the early prediction and monitoring of the disease in a future.